Korea University Medicine, Taiwan Alliance of Clinical Trial Centers, and Avance Clinical Convene Regional Collaboration Event in Seoul

Avance Clinical’s Growing Asia-Pacific Footprint

Avance Clinical operates offices in Seoul and Taipei, with staff most recently added in mainland China. The company services international biotechs across more than 250 indications, with particular specialization in:

• Early-phase and First-in-Human (FIH) studies
• Oncology
• Renal, Cardio, and Metabolic disease
• Central Nervous System (CNS) trials

What Happened at the Event

The Seoul event gave participating organizations a platform to:

1. Exchange perspectives on the evolving clinical trial landscape
2. Discuss each institution’s research infrastructure and clinical development capabilities
3. Identify areas of mutual interest for future collaboration

Representatives from KUM, TACTC, and Avance Clinical delivered presentations on their respective research infrastructure and clinical development expertise, with additional participation from Taipei Medical University. The program concluded with an interactive discussion on cross-border collaboration, knowledge exchange, and future partnership opportunities.

Why Regional Collaboration Matters

As the global clinical research environment becomes increasingly interconnected, partnerships between medical institutions, alliance platforms, and industry players play a critical role in:

• Facilitating scientific advancement
• Enhancing research quality
• Supporting efficient development of innovative therapies for patients